- Polyvinylpyrrolidone (PVP) is a non‑permeating, polymeric cryoprotective agent widely used in cryobiology to enhance cell and tissue survival during freezing and thawing. Unlike permeating CPAs such as DMSO, ethylene glycol, or propylene glycol, PVP remains extracellular and protects cells by modifying water behaviour, stabilizing membranes, and reducing mechanical stress associated with ice formation. Its polymeric nature makes PVP particularly valuable in slow freezing protocols, reproductive cryobiology, and the preservation of sensitive cell types where minimizing intracellular CPA exposure is essential.
- PVP is a synthetic polymer composed of repeating N‑vinylpyrrolidone units. Its high molecular weight and hydrophilic nature allow it to bind water molecules, increase solution viscosity, and reduce ice nucleation. During cooling, PVP promotes controlled cellular dehydration by increasing extracellular osmotic pressure. This controlled dehydration reduces the likelihood of intracellular ice formation, one of the most damaging events in cryopreservation. Because PVP does not enter the cell, it avoids many toxicity issues associated with permeating CPAs and provides a gentler protective environment.
- The cryoprotective mechanism of PVP involves several synergistic effects. First, PVP increases solution viscosity, slowing ice crystal growth and reducing mechanical stress on cell membranes. Second, it interacts with extracellular surfaces, stabilizing membrane structure during temperature‑induced phase transitions. Third, PVP helps maintain osmotic balance during thawing, preventing excessive swelling that can rupture membranes. These properties make PVP particularly effective when combined with permeating CPAs, creating mixtures that reduce the concentration of toxic agents while improving overall cryoprotection. More details on CPA combinations are available in Cryoprotective Agents.
- Polyvinylpyrrolidone is widely used in reproductive biology, especially in the cryopreservation of spermatozoa and embryos. In sperm freezing, PVP improves motility recovery and reduces membrane damage by stabilizing the extracellular environment. In embryo cryopreservation, PVP is often included in slow‑freezing solutions to reduce ice formation and enhance post‑thaw developmental potential. PVP is also used in the cryopreservation of oocytes in certain species, where its ability to reduce mechanical stress is particularly beneficial.
- Beyond reproductive applications, PVP is used in the preservation of stem cells, immune cells, and various tissues. Its low toxicity and membrane‑stabilizing properties make it suitable for protocols requiring long exposure times or reduced permeating CPA concentrations. In organ cryobiology, PVP is being explored as part of polymer‑based CPA mixtures designed to support low‑temperature storage of complex tissues.
- Toxicity is generally low for polyvinylpyrrolidone, especially compared with permeating CPAs. However, high concentrations can increase solution viscosity excessively, complicating cooling rates and handling. Different molecular weights of PVP behave differently: higher‑molecular‑weight PVP provides stronger ice suppression but may increase osmotic stress, while lower‑molecular‑weight PVP offers gentler protection but weaker vitrification support. Selecting the appropriate PVP formulation is therefore essential for optimizing cryopreservation outcomes. Toxicity considerations are discussed further in Cryoprotectant Toxicity.
- Overall, polyvinylpyrrolidone remains an important non‑permeating cryoprotectant in modern cryobiology. Its ability to reduce ice formation, stabilize membranes, and lower reliance on permeating CPAs makes it a valuable component of many freezing protocols. As research advances toward organ cryopreservation, biobanking, and regenerative medicine, PVP continues to play a key role in improving the safety and effectiveness of low‑temperature biological storage.
